Literature DB >> 408032

[Branchial vascularization in the eel: action of acetylcholine and adrenaline on the distribution of polymerizable resin in the different vascular compartments].

S Dunel, P Laurent.   

Abstract

The current findings from gill vascular cast preparations in the eel emphasize the division in each primary lamella of the afferent vasculature into two efferent pathways: an arterial pathway (via the secondary lamellae and the efferent branchial artery to the dorsal aorta), a venous pathway (via the central lamellar compartment and the branchial vein to the sinus venosus). By the same technique two antagonist mechanisms have been shown presumably controlling the blood flow in both pathways. 1. Acetylcholine increases the filling of the central lamellar compartment by constricting the efferent arterial sphincters and therefore increases the venous return. 2. Epinephrine impairs the filling of the central lamellar compartment (by acting on alpha receptors) and dilates the arterial pathway (by acting on beta receptors). Therefore the stimulation of these two synergic receptors by epinephrine increases the systemic blood flow.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 408032

Source DB:  PubMed          Journal:  C R Acad Hebd Seances Acad Sci D


  4 in total

1.  Morphology and vascular anatomy of the gills of a primitive air-breathing fish, the bowfin (Amia calva).

Authors:  K R Olson
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

2.  Effects of perfusion pressure on the morphology of the central sinus in the trout gill filament.

Authors:  K R Olson
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

3.  Vascular organization of the catfish gill filament.

Authors:  E J Boland; K R Olson
Journal:  Cell Tissue Res       Date:  1979-05-25       Impact factor: 5.249

Review 4.  Fish acute toxicity syndromes and their use in the QSAR approach to hazard assessment.

Authors:  J M McKim; S P Bradbury; G J Niemi
Journal:  Environ Health Perspect       Date:  1987-04       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.